India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and ...

India has emerged as an increasingly significant player in the illicit fentanyl trade, according to a new intelligence report ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three sessions, experts believe the panic is unfounded, maintaining confidence in ...

Hyderabad: The National Company Law Tribunal has sanctioned the scheme of amalgamation between contract development and ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

The financial services company suggests that India will need to strive harder to gain opportunities from a global tariff war.

The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.